プログラム
*Alphabetical order in each session.
1日目 / Day 1
Vaccine/Infectious Diseases
- Germinal centers, TFH cells, and immunodominance in vaccine immunology
- Shane CrottyLa Jolla Institute for Immunology, U.S.A.
- Immunology of long COVID
- Akiko IwasakiYale School of Medicine, U.S.A.
- Clonal dynamics in the steady state and in the immune response
- Antonio LanzavecchiaNational Institute of Molecular Genetics, Italy
- Systems Vaccinology
- Bali PulendranStanford University, U.S.A.
- Deconstructing the form and function of T cell responses to pathogens and tumors
- Paul G. ThomasSt. Jude Children's Research Hospital, U.S.A.
Genome/Epigenome
- A Single Cell View of the Infant Immune System
- Jacques Banchereau Immunai, U.S.A.
- Systems immunology of human immune set points
- John S. TsangYale School of Medicine, U.S.A.
- Genomics and multi-omics studies to understand human immune system
- Kazuhiko YamamotoRIKEN Center for Integrative Medical Sciences, Japan
Resident Immune Cells in Human Organs
- Tissue and age determinants of the human immune system
- Donna Farber Columbia University, U.S.A.
- Regulation of IL-15-induced bystander CD8+ T cell activation
- Eui‐Cheol Shin Korea Advanced Institute of Science and Techonology (KAIST), Korea
- The human liver immune system
- Hideki UenoKyoto University, Japan
2日目 / Day 2
Primary Immunodeficiency / Autoimmune Diseases
- Human genetic and immunological determinants of infectious diseases
- Jean-Laurent CasanovaThe Rockefeller University, U.S.A.
- Human Immune Organoids to understand vaccination and autoimmunity
- Mark Davis Stanford University School of Medicine, U.S.A.
- Systemic Lupus Erythematosus: Interferon and Beyond
- Virginia PascualWeill Cornell Medical College, U.S.A.
- Defining genetic mechanisms of autoimmunity
- Soumya RaychaudhuriHarvard Medical School, U.S.A.
- T cell activation, differentiation and immune regualation
- Federica SallustoETH Zurich, Switzerland
Cancer Immunology
- Epigenetic control of immune responses
- Sebastian AmigorenaMemorial Sloan Kettering Cancer Center, France
- Immuno-genomic cancer evolution governs immune landscapes in the tumor microenvironment
- Hiroyoshi NishikawaNational Cancer Center / Nagoya University, Japan
- Cancer rearranges the rules in tissue building blocks. A new class of targets for therapy?
- Garry NolanStanford Medicine, U.S.A.
- Antigen sensitivity, logic gating and persistence of CAR T cells
- Michel SadelainMemorial Sloan Kettering Cancer Center, U.S.A.
- Novel checkpoints in T cells and APCs
- Weiping ZouUniversity of Michigan, U.S.A.